FDA
approval
· 2020-11-13
FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
FDA approved a supplemental application for TRINTELLIX (vortioxetine) by Takeda Pharmaceuticals America, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRINTELLIX (VORTIOXETINE)